Evidence map›Paper›PMID 37737266›Full record

ArticleJCI insight2023

MicroRNA-1 protects the endothelium in acute lung injury.

Asawari Korde, Maria Haslip, Prachi Pednekar, Alamzeb Khan, Maurizio Chioccioli, Sameet Mehta, Francesc Lopez-Giraldez, Santos Bermejo, Mauricio Rojas, Charles Dela Cruz and 4 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Acute lung injury: pathogenesis and treatment.Journal of translational medicine · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Asawari KordeDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Maria HaslipDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Prachi PednekarDepartment of Medicine, Yale New Haven Hospital, New Haven, Connecticut, USA.
Alamzeb KhanDepartment of Immunobiology, and.
Maurizio ChioccioliDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Sameet MehtaDepartment of Genetics, Yale University School Medicine, New Haven, Connecticut, USA.
Francesc Lopez-GiraldezDepartment of Genetics, Yale University School Medicine, New Haven, Connecticut, USA.
Santos BermejoDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Mauricio RojasDivision of Pulmonary, Critical Care and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Charles Dela CruzDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Michael A MatthayCardiovascular Research Institute, Department of Medicine and Anesthesiology, UCSF, San Francisco, California, USA.
Jordan S PoberDepartment of Immunobiology, and.
Richard W PierceDepartment of Immunobiology, and.
Shervin S TakyarDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · USThe Ohio State University · USUniversity of California, San Francisco · USYale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Molecular regulation of the capillary barrier in acute critical illnessR01HL170164 · NHLBI · YALE UNIVERSITY · PI RICHARD W PIERCE · 2023 to 2026
$2.3M
Mechanisms of Endothelial Cell Dysfunction in Critically Ill ChildrenK08HL136898 · NHLBI · YALE UNIVERSITY · PI PIERCE, RICHARD W · 2019 to 2023
$780k
MiR-1 is a Critical Regulator of VEGF-Induced AngiogenesisR00HL098695 · NHLBI · YALE UNIVERSITY · PI TAKYAR, SEYEDTAGHI · 2013 to 2015
$730k
Cancer Bioinformatics: Data analysis and method development for the Yale Cancer CenterR50CA265359 · NCI · YALE UNIVERSITY · PI Juan Francisco Lopez Giraldez · 2022 to 2026
$699k
MiR-1 is a Critical Regulator of VEGF-Induced AngiogenesisK99HL098695 · NHLBI · YALE UNIVERSITY · PI TAKYAR, SEYEDTAGHI · 2010 to 2012
$237k
NCATS NIH HHS UL1 TR001863NCI NIH HHS R50 CA265359NHLBI NIH HHS K08 HL136898NHLBI NIH HHS K99 HL098695NHLBI NIH HHS R00 HL098695NHLBI NIH HHS R01 HL170164
6 · The paper itself

Abstract

Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), cause severe endothelial dysfunction in the lung, and vascular endothelial growth factor (VEGF) is elevated in ARDS. We found that the levels of a VEGF-regulated microRNA, microRNA-1 (miR-1), were reduced in the lung endothelium after acute injury. Pulmonary endothelial cell-specific (EC-specific) overexpression of miR-1 protected the lung against cell death and barrier dysfunction in both murine and human models and increased the survival of mice after pneumonia-induced ALI. miR-1 had an intrinsic protective effect in pulmonary and other types of ECs; it inhibited apoptosis and necroptosis pathways and decreased capillary leak by protecting adherens and tight junctions. Comparative gene expression analysis and RISC recruitment assays identified miR-1 targets in the context of injury, including phosphodiesterase 5A (PDE5A), angiopoietin-2 (ANGPT2), CNKSR family member 3 (CNKSR3), and TNF-α-induced protein 2 (TNFAIP2). We validated miR-1-mediated regulation of ANGPT2 in both mouse and human ECs and found that in a 119-patient pneumonia cohort, miR-1 correlated inversely with ANGPT2. These findings illustrate a previously unknown role of miR-1 as a cytoprotective orchestrator of endothelial responses to acute injury with prognostic and therapeutic potential.

Indexed as

Acute Lung InjuryMicroRNAsRespiratory Distress SyndromeAnimalsEndotheliumHumansMiceVascular Endothelial Growth Factor AMicroRNAsMIRN1 microRNA, humanMirn1 microRNA, mouseVascular Endothelial Growth Factor AEndothelial cellsNoncoding RNAsPulmonologyVascular Biology

Identifiers

PMID37737266
PMCPMC10561733
OpenAlexW4386917212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.